Factores asociados a albuminuria en pacientes diabéticos en su primera consulta nefrológica

  • Percy Herrera Añazco Hospital Nacional Dos de Mayo, Lima
  • Luis Bonilla Vargas TB/STI Epidemiology Consultant CTS Global for Centers for Disease Control and Prevention (CDC), Santo Domingo
  • Melissa Palacios Guillén Hospital Nacional Daniel Alcides Carrión, Bellavista - Callao
  • José Valencia Rodríguez Hospital Nacional Dos de Mayo, Lima
  • Flor Sánchez Riva Hospital Nacional Arzobispo Loayza, Ministerio de Salud del Perú, Lima
  • Jorge Salomé Luna Hospital María Auxiliadora, San Juan de Miraflores
  • Manuela Silveira Chau Clínica Internacional, Lima

Resumen

Introducción: Determinar cuáles son los factores asociados a albuminuria en pacientes diabéticos tipo 2 que acuden por primera vez a una consulta nefrológica en hospitales públicos de Lima. Material y métodos: Estudio multicéntrico de los pacientes diabéticos en su primera consulta nefrológica en el Hospital Nacional 2 de Mayo, Hospital Nacional Arzobispo Loayza, Hospital Daniel Alcides Carrión y Hospital María Auxiliadora entre septiembre 2011 y febrero 2012. Se realizó un análisis multivariado mediante regresión logística de los factores de riesgo para albuminuria. Resultados: Se estudiaron 200 pacientes diabéticos con edad media de 60,3 años. El 70% eran hipertensos, el 36,5% eran obesos, el 52,8% tenía dislipidemia y el 57% tenía una TFG < 60 ml/min. El 26,85% tenía albuminuria menor de 30 mg/24 horas; el 23,15% tenía albuminuria entre 30 a 300 mg/24horas y el 50% tenía albuminuria mayor de 300 mg/24 horas. El 11,11% de los pacientes en ERC estadio 5 no cursó con albuminuria. En el análisis multivariado la abuminuria se asoció a sexo femenino OR 3,721 (p=0.024) y al estadio de la ERC OR 1,926 (p=0.007). Conclusiones: Más de las tres cuartas partes de nuestros pacientes llegan a consulta con albuminuria y está asociada a sexo femenino y estadio de la ERC.

Citas

Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012;35(6):1364-79.

de Boer IH, Rue TC, Hall YN, Heagerty PJ, Weiss NS, Himmelfarb J. Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA. 2011;305(24):2532-9.

Molitch ME, DeFronzo RA, Franz MJ, Keane WF, Mogensen CE, Parving HH, et al. Nephropathy in diabetes. Diabetes Care. 2004;27(Suppl 1):S79-83.

KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis. 2007;49(2 Suppl 2):S12-154.

United States Renal Data System. Annual data report 2009. Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States [Internet]. Bethesda, MD: 2009. Disponible en: https://www.usrds.org/atlas09.aspx (citado: 28/01/2011).

KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl. 2013; 1(3):1-150.

Breyer JA. Diabetic nephropathy in insulin-dependent patients. Am J Kidney Dis. 1992;20(6):533-47.

Nitsch D, Grams M, Sang Y, Black C, Cirillo M, Djurdjev O, et al. Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis. BMJ. 2013;346:f324.

Astor BC, Matsushita K, Gansevoort RT, van der Velde M, Woodward M, Levey AS, et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int. 2011;79(12):1331-40.

Gansevoort RT, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, et al. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int. 2011;80(1):93-104.

Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375(9731):2073-81.

van der Velde M, Matsushita K, Coresh J, Astor BC, Woodward M, Levey A, et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int. 2011;79(12):1341-52.

Rossi MC, Nicolucci A, Pellegrini F, Comaschi M, Ceriello A, Cucinotta D, et al. Identifying patients with type 2 diabetes at high risk of microalbuminuria: results of the DEMAND (Developing Education on Microalbuminuria for Awareness of reNal and cardiovascular risk in Diabetes) Study. Nephrol Dial Transplant. 2008;23(4):1278-84.

Yokoyama H, Sone H, Oishi M, Kawai K, Fukumoto Y, Kobayashi M. Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDM15). Nephrol Dial Transplant. 2009;24(4):1212-9.

Afghahi H, Cederholm J, Eliasson B, Zethelius B, Gudbjörnsdottir S, Hadimeri H, et al. Risk factors for the development of albuminuria and renal impairment in type 2 diabetes--the Swedish National Diabetes Register (NDR). Nephrol Dial Transplant. 2011;26(4):1236-43.

Jia W, Gao X, Pang C, Hou X, Bao Y, Liu W, et al. Prevalence and risk factors of albuminuria and chronic kidney disease in Chinese population with type 2 diabetes and impaired glucose regulation: Shanghai diabetic complications study (SHDCS). Nephrol Dial Transplant. 2009;24(12):3724-31.

Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR; UKPDS Study Group. Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. Diabetes. 2006;55(6):1832-9.

Jefferson JA, Shankland SJ, Pichler RH. Proteinuria in diabetic kidney disease: a mechanistic viewpoint. Kidney Int. 2008;74(1):22-36.

Vidal Pardo JI, Pérez Castro TR, López Álvarez XL, García Soidán FJ, Santiago Pérez MI, Muñiz J. Quality of care of patients with type-2 diabetes in Galicia (NW Spain) [OBTEDIGA project]. Int J Clin Pract. 2011;65(10):1067-75.

Hermans MP, Brotons C, Elisaf M, Michel G, Muls E, Nobels F. Optimal type 2 diabetes mellitus management: the randomised controlled OPTIMISE benchmarking study: baseline results from six European countries. Eur J Prev Cardiol. 2013;20(6):1095-105.

Phillips LS, Branch WT, Cook CB, Doyle JP, El-Kebbi IM, Gallina DL, et al. Clinical inertia. Ann Intern Med. 2001;135(9):825-34.

Phillips LS, Twombly JG. It's time to overcome clinical inertia. Ann Intern Med. 2008;148(10):783-5.

Streja DA, Rabkin SW. Factors associated with implementation of preventive care measures in patients with diabetes mellitus. Arch Intern Med. 1999;159(3):294-302.

Bardelli-Guibovich M, Castillo-Campos R, Medina- Sánchez C. Microalbuminuria y factores de riesgo cardiovascular en hipertensos: resultados de Perú del estudio global i-SEARCH. Rev Soc Peru Med Interna. 2012;25(1):11-7.

National Campaign of World Kidney Day 2010; Peruvian Society of Nephrology. Microalbuminuria in adult outpatients not receiving nephrological care and with risk factors for chronic kidney disease in Peruvian nephrology departments. Nefrologia. 2012;32(2):180-6.

Núñez-Moscoso LE. Prevalencia de la microalbuminuria en pacientes con diabetes mellitus tipo 2 en un hospital de nivel 1 de Arequipa. Rev Soc Peru Med Interna. 2010;23(4):140-4.

Publicado
2017-08-23
Cómo citar
1.
Herrera Añazco P, Bonilla Vargas L, Palacios Guillén M, Valencia Rodríguez J, Sánchez Riva F, Luna JS, Silveira Chau M. Factores asociados a albuminuria en pacientes diabéticos en su primera consulta nefrológica. Rev Nefrol Dial Traspl. [Internet]. 23 de agosto de 2017 [citado 18 de julio de 2024];33(2):85-1. Disponible en: http://revistarenal.org.ar/index.php/rndt/article/view/165
Sección
Artículo Original